TP53 and MDM2 Polymorphisms and the Risk of Endometrial Cancer in Postmenopausal Women

Medical Oncology- United States

doi 10.1007/s12032-014-0286-z

Full Text

Abstract

Available in

Categories

Cancer Research

Date

October 15, 2014

Authors

Agnieszka Zając

Grzegorz Stachowiak

Jacek R. Wilczyński

Publisher

Springer Science and Business Media LLC

Related search

TP53 and MDM2 Gene Polymorphisms and Risk of Hepatocellular Carcinoma in Italian Patients

Infectious Agents and Cancer

Cancer Research

Infectious Diseases

English

Endometrial Polyps in Postmenopausal Women

Acta Obstetricia et Gynecologica Scandinavica

English

The Effects of Obesity and HER-2 Polymorphisms as Risk Factors for Endometrial Cancer in Korean Women

BJOG: An International Journal of Obstetrics and Gynaecology

English

Genetic Polymorphisms in Obesity-Related Genes and Endometrial Cancer Risk

Cancer Research

English

The Obesity-Associated Polymorphisms FTO Rs9939609 and Mc4r Rs17782313 and Endometrial Cancer Risk in Non-Hispanic White Women

Multidisciplinary

English

Timing of Births and Endometrial Cancer Risk in Swedish Women

Cancer Causes and Control

Cancer Research

English

Metabolic Obesity Phenotypes and Risk of Breast Cancer in Postmenopausal Women

Cancer Epidemiology Biomarkers and Prevention

English

Combined Mineral Intakes and Risk of Colorectal Cancer in Postmenopausal Women

Cancer Epidemiology Biomarkers and Prevention

English

Physical Activity and Risk of Breast Cancer Among Postmenopausal Women

Archives of Internal Medicine

English